• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Cerner Integrates EHR to Prescription Drug Monitoring Programs in 46 States

by Jasmine Pennic 05/14/2019 Leave a Comment

Opioid Crisis Survey: Patients Support Prescription Monitoring Programs

As states mandate the physician’s review of prescription drug data, it is increasingly important that they can quickly access critical drug information directly within a person’s electronic health record (EHR). Today, Cerner has announced that it will launch a nationwide connection from the EHR to each state’s prescription drug monitoring program (PDMP), creating quicker and more efficient access through a partnership with medication management provider DrFirst. In partnership with DrFirst, Cerner will be able to connect the EHR to PDMPs in 46 states and Washington, D.C., with other states expected as they become available.

Benefits of EHR-Integrated State Prescription Drug Monitoring Programs (PDMP)

The integration will support safer pain management, the ability to identify and mitigate risk factors and more easily manage populations at high risk for substance use disorder. As the opioid epidemic continues to grow, it’s important that we inform safer prescribing and advance timely engagement with people to prevent or alleviate substance use disorder.

Without a more efficient connection to PDMPs, physicians must deal with the cumbersome workflow disruption of accessing external web portals. Streamlining the connection so that prescription drug data appears in a person’s EHR can give back valuable time to providers for patient interactions and conversations about preventing or alleviating substance use disorder. Quicker and straightforward access to this information can also ease compliance with regulatory requirements.

“Access to prescription drug data within and across state lines can help identify and prevent drug-seeking behaviors, as well as inform physicians of a person’s history to help avoid misuse and guide treatment decisions,” said Eva Karp, senior vice president and chief clinical and patient safety officer, Cerner. “At a time when the opioid epidemic continues to grow, it’s important that we transform health care for the patient, advancing smarter pain management and timely engagement with individuals to prevent or alleviate substance use disorder. Our work with DrFirst to expedite connections to PDMPs is part of our ongoing commitment to relentlessly seek breakthrough innovation to shape the health care of tomorrow.”

Tagged With: Cerner, DrFirst, Electronic Health Record, medication, Opioid Epidemic, Opioid Prescriptions, Pain Management, patient safety, physicians, Prescription Drug Monitoring Program, Prescription drug monitoring programs (PDMPs), risk, WASHINGTON

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |